Skip to main content
Fig. 1 | Journal of Nanobiotechnology

Fig. 1

From: Promising PEGylated cationic dendrimers for delivery of miRNAs as a possible therapy against HIV-1 infection

Fig. 1

Cytotoxicity of cationic carbosilane dendrimers by MTT assay. PBMCs (a) and U87MG-CD4+CCR5+ cells (b) were treated in a range of concentrations from 0.01 to 30 µM of each cationic dendrimer. Cell viability > 80% was established as non-toxic concentration. Culture medium samples were used as cell viability control and DMSO 10% was used as death control. Data represented as mean ± SD of three individual experiments performed in triplicate. DMSO dimethyl sulfoxide 10%, NT non-treated

Back to article page